secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2023-09-12T23:59:59+00:00
Accession:  0000926617-23-000077
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health CSO/COO Ryan Phan resigns, transitions to advisor
-----------------------------------------------------------------------

- Dr. Ryan Phan resigns as Chief Scientific & Operating Officer effective Sept 15, 2023, becomes advisor Sept 16, 2023.
- Consulting agreement pays $20,000/month through Jan 15, 2024; options continue vesting during term.
- $50,000 retention bonus forgiven if Phan remains employed through Dec 31, 2023.
- Phan to continue as CLIA lab medical director until Jan 15, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000092661723000077/0000926617-23-000077-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000092661723000077/awh-20230907x8k.htm
  HTML page:      https://secwatch.observer/filing/0000926617-23-000077

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer